MENU
+Compare
PMN
Stock ticker: NASDAQ
AS OF
Jan 15, 04:27 PM (EDT)
Price
$8.15
Change
+$0.01 (+0.12%)
Capitalization
17.52M

PMN Promis Neurosciences Inc. Forecast, Technical & Fundamental Analysis

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA)... Show more

PMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PMN with price predictions
Jan 14, 2026

PMN in upward trend: price expected to rise as it breaks its lower Bollinger Band on December 30, 2025

PMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 51 cases where PMN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PMN's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 12, 2026. You may want to consider a long position or call options on PMN as a result. In of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PMN just turned positive on January 07, 2026. Looking at past instances where PMN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PMN advanced for three days, in of 178 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PMN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.907) is normal, around the industry mean (27.929). P/E Ratio (7.778) is within average values for comparable stocks, (51.397). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.899). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (329.547).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PMN is expected to report earnings to fall 14.58% to -20 cents per share on April 06

Promis Neurosciences Inc. PMN Stock Earnings Reports
Q4'25
Est.
$-0.20
Q3'25
Est.
$-0.24
Q2'25
Missed
by $0.13
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.28
The last earnings report on November 12 showed earnings per share of -23 cents, meeting the estimate of -23 cents. With 1.26K shares outstanding, the current market capitalization sits at 17.52M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COCP1.160.07
+6.42%
Cocrystal Pharma
ASX18.880.18
+0.96%
ASE Technology Holding Co Ltd
FNKO3.570.03
+0.85%
Funko
TCBI96.640.78
+0.81%
Texas Capital Bancshares
YEXT7.650.01
+0.13%
Yext

PMN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with NEVPF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
-0.25%
NEVPF - PMN
49%
Loosely correlated
N/A
CNSP - PMN
49%
Loosely correlated
+0.98%
SYRE - PMN
44%
Loosely correlated
+5.17%
BBIO - PMN
42%
Loosely correlated
-1.53%
ABOS - PMN
33%
Poorly correlated
+3.47%
More